Abstract
Providing effective information about drug risks and benefits has become a major challenge for health professionals, as many people are ill equipped to understand, retain and use the information effectively. This paper reviews the growing evidence that peoples understanding (and health behaviour) is not only affected by the content of medicines information, but also by the particular way in which it is presented. Such presentational factors include whether information is presented verbally or numerically, framed positively or negatively, whether risk reductions are described in relative or absolute terms (and baseline information included), and whether information is personalized or tailored in any way. It also looks at how understanding is affected by the order in which information is presented, and the way in which it is processed. The paper concludes by making a number of recommendations for providers of medicines information, about both the content and presentation of such information, that should enhance safe and effective medicines usage.
Keywords: Medicines information, risk communication, medicine benefits, probability descriptors, framing, message tailoring
Current Drug Safety
Title: Informing People about the Risks and Benefits of Medicines: Implications for the Safe and Effective Use of Medicinal Products
Volume: 1 Issue: 1
Author(s): Dianne C. Berry
Affiliation:
Keywords: Medicines information, risk communication, medicine benefits, probability descriptors, framing, message tailoring
Abstract: Providing effective information about drug risks and benefits has become a major challenge for health professionals, as many people are ill equipped to understand, retain and use the information effectively. This paper reviews the growing evidence that peoples understanding (and health behaviour) is not only affected by the content of medicines information, but also by the particular way in which it is presented. Such presentational factors include whether information is presented verbally or numerically, framed positively or negatively, whether risk reductions are described in relative or absolute terms (and baseline information included), and whether information is personalized or tailored in any way. It also looks at how understanding is affected by the order in which information is presented, and the way in which it is processed. The paper concludes by making a number of recommendations for providers of medicines information, about both the content and presentation of such information, that should enhance safe and effective medicines usage.
Export Options
About this article
Cite this article as:
Berry C. Dianne, Informing People about the Risks and Benefits of Medicines: Implications for the Safe and Effective Use of Medicinal Products, Current Drug Safety 2006; 1 (1) . https://dx.doi.org/10.2174/157488606775252638
DOI https://dx.doi.org/10.2174/157488606775252638 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer
Current Drug Targets CD4+CD25+ Regulatory T-Cell Therapy for Allergy, Autoimmune Disease and Transplant Rejection
Inflammation & Allergy - Drug Targets (Discontinued) The Physiological Basis of Respiratory Sensation
Current Respiratory Medicine Reviews Effects of Edible Algae Polysaccharides on Allergic, Inflammatory, and Anti-Tumor Responses Through Toll-Like Receptor 4
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Should We Develop an Inhaled Anti-pneumococcal Vaccine for Adults?
Current Medicinal Chemistry - Anti-Infective Agents Adenosine A<sub>3</sub> Receptor: A promising therapeutic target in cardiovascular disease
Current Cardiology Reviews Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Patent Selections:
Current Biomarkers (Discontinued) Dietary Interventions in Asthma
Current Pharmaceutical Design Diabetic Theory in Anti-Alzheimer’s Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors
Current Medicinal Chemistry Dendritic Nanoparticles for Cutaneous Drug Delivery - Testing in Human Skin and Reconstructed Human Skin
Current Pharmaceutical Design Assessment of Herb-drug Interactions Based on the Pharmacokinetic Changes of Probe Drug, Midazolam
Drug Metabolism Letters Recombinant Proteins and Peptides as Diagnostic and Therapeutic Reagents for Arthropod Allergies
Protein & Peptide Letters Pharmacogenomics and Severe Infections: The Role of the Genomes of Both the Host and the Pathogen
Current Pharmacogenomics Towards Systems Biology of Respiratory Syncytial Virus Infections:Seeing the Need and Preparing for Prime Time
Current Respiratory Medicine Reviews Prevalence of Intestinal Parasites among Patients with Chronic Urticaria in Northern Iran
Infectious Disorders - Drug Targets Subject Index Volume 6
Mini-Reviews in Medicinal Chemistry Beta-2 Agonists in Asthma: Medicine or Murderer?
Current Respiratory Medicine Reviews Microvascular Theory of Exercise-Induced Bronchoconstriction in Asthma: Potential Implication of Vascular Endothelial Growth Factor
Inflammation & Allergy - Drug Targets (Discontinued) IL-13: A Promising Therapeutic Target for Bronchial Asthma
Current Medicinal Chemistry